𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Arsenic induces DNA damage via reactive oxygen species in human cells

✍ Scribed by Dasheng Li; Kanehisa Morimoto; Tatsuya Takeshita; Yuquan Lu

Publisher
Japan Science and Technology Information Aggregator, Electronic
Year
2001
Tongue
English
Weight
288 KB
Volume
6
Category
Article
ISSN
1342-078X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genistein selectively potentiates arseni
Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK)
✍ Yolanda Sánchez; Donna Amrán; Carlos Fernández; Elena de Blas; Patricio Aller 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 626 KB

## Abstract The observation that genistein may behave as a pro‐oxidant agent lead us to examine the capacity of this isoflavone to modulate the toxicity of the oxidation‐sensitive anti‐leukemic agent arsenic trioxide (ATO), and for comparison other anti‐tumor drugs. Co‐treatment with genistein incr

Plumbagin induces reactive oxygen specie
Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells
✍ Priya Srinivas; Gokul Gopinath; Asoke Banerji; Abhilash Dinakar; Gopal Srinivas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB

## Abstract There is an emerging evidence that plumbagin (5‐hydroxy‐2‐methyl‐1, 4‐naphthoquinone) may have potential as a chemotherapeutic agent. However, the growth inhibitory mechanisms of plumbagin have remained unexplored. The aim of the study was to determine whether plumbagin‐induced cell dea

Aminoflavone induces oxidative DNA damag
Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells
✍ Lancelot McLean; Ubaldo Soto; Keli Agama; Jawad Francis; Randi Jimenez; Yves Pom 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 409 KB 👁 1 views

## Abstract Aminoflavone (5‐amino‐2‐(4‐amino‐3‐fluorophenyl)‐6,8‐difluoro‐7‐methylchromen‐4‐one; AF; NSC 686288), a novel anticancer candidate agent, is undergoing clinical evaluation. AF induces DNA‐protein cross‐links (DPCs), γ‐H2AX phosphorylation, aryl hydrocarbon receptor (AhR) signaling, apop